Post by
deepoil0808 on Mar 14, 2024 4:32pm
200 day moving average $ 2.13/share
Looks like we are heading towards the 200 day moving average of $2.13 per share. Pretty steep slope so far.
If it breaks this support, then it confirms that the trials may not be going as planned.
The fact that observers are able to physically see the progression in a patient, makes it difficult to kept results secret.
Hence plunge in stock is not very reassuring.
Good Luck,